Showing results (1041-1050 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|July 29, 2014
UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational studyEilis C Bragginton, Laura J V Piddock
The Lancet. Infectious Diseases|July 29, 2014
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyRobert M Grant, Peter L Anderson, Vanessa McMahan, et al.
The Lancet. Infectious Diseases|December 3, 2013
Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trialsZulfiqar A Bhutta, Maria Rosario Capeding, Ashish Bavdekar, et al.
The Lancet. Infectious Diseases|August 10, 2014
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional studySepehr N Tabrizi, Julia M L Brotherton, John M Kaldor, et al.
The Lancet. Infectious Diseases|April 9, 2013
Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysisFrédérique Chammartin, Ronaldo G C Scholte, Luiz H Guimarães, et al.
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trialEric Lawitz, Jay P Lalezari, Tarek Hassanein, et al.
The Lancet. Infectious Diseases|February 19, 2013
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessmentUlrich Vogel, Muhamed-Kheir Taha, Julio A Vazquez, et al.
The Lancet. Infectious Diseases|February 23, 2013
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approachRichard S Hotchkiss, Guillaume Monneret, Didier Payen
The Lancet. Infectious Diseases|February 2, 2013
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyMarc Gurwith, Michael Lock, Eve M Taylor, et al.
The Lancet. Infectious Diseases|January 26, 2013
Rapidly growing mycobacterial bloodstream infectionsGilbert El Helou, George M Viola, Ray Hachem, et al.
Pageof 270